Erectile dysfunction, chronic prostatitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. 18 = 10 points and symptoms such as frequent urination and urination discomfort last for at least 6 months; 5. Those who have not used other methods including PDE5i to treat ED within 4 weeks before grouping; 6. Overall good health, having a stable heterosexual partner for more than 3 months; 7. Sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Organic ED; 2. Uncontrollable systemic hemorrhagic disease, medical history of bleeding tendency; 3. Severe arrhythmia in patients with poor blood pressure control (systolic blood pressure >= 160 mmHg and diastolic blood pressure >= 100 mmHg after treatment); 4. Patients with poor blood sugar control, that is, HbA1c >= 13%; 5. Unstable angina; 6. Diseases that hinder the safe participation of the experimental design and affect the completion of the study, such as myocardial infarction or stroke, congestive heart failure, severe chronic obstructive pulmonary disease, cancer, serious systemic disease and severe mental illness in the past 3 months; 7. Those who are allergic to the drugs in the test (doxazosin, tadalafil, etc.) or have contraindications (such as currently using anticoagulants and nitrates, etc.); 8. Recent (within 3 months) history of myocardial infarction; 9. Have a history of gastrointestinal obstruction, esophageal obstruction or any degree of narrowing of the lumen of the gastrointestinal tract; 10. Participating in other clinical research; 11. Other researchers think that they are not suitable for participating in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| International Index of Erectile Function;Chronic Prostatitis Symptom Scale; | — |
Countries
China
Contacts
Xiangya Hospital, Central South University